Given the potential capability of IL-17 and iNOS to upregulate PGE2 and IL-1β, which causes pain [30] or raise the sensibility to algesia [31], IL-17 and iNOS may be the candidates for exerting an influence on LBP. This evidence concerns the gene IL17A and Low back pain.